/ Not yet recruiting临床1期IIT A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Eltrombopag 25 mg tablets relative to Revolade 25 mg tablets in healthy Thai volunteers under fasting condition.
/ Not yet recruiting临床1期IIT A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Empagliflozin Film-Coated Tablets 25 mg relative to JARDIANCE (Empagliflozin Film-Coated Tablets 25 mg) in healthy Thai volunteers under fasting condition
/ Not yet recruiting临床1期IIT A bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two treatment and two-sequence of Dienogest Tablet 2 mg relative to Visanne (original Dienogest Tablet 2 mg) in healthy Thai female volunteers under fasting condition
100 项与 Bio-innova Co., Ltd 相关的临床结果
0 项与 Bio-innova Co., Ltd 相关的专利（医药）
100 项与 Bio-innova Co., Ltd 相关的药物交易
100 项与 Bio-innova Co., Ltd 相关的转化医学
